Promoter polymorphism of the CD14 endotoxin receptor gene and primary biliary cirrhosis [4]

Hepatology

Volumn 35, Issue 1, 2002, Pages 242-243

  Corpechot, C ^a   Poupon, R ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CD14 ANTIGEN; CD14 ENDOTOXIN RECEPTOR; DNA; ENDOTOXIN; MITOCHONDRION ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ALLELE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; LETTER; LEUKOCYTE; LIVER HISTOLOGY; POLYMERASE CHAIN REACTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0036138578     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.30279     Document Type: Letter

References (8)

1. Promoter polymorphism of the CD 14 endotoxin receptor gene as a risk factor for alcoholic liver disease
2. A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E
3. Antibody activity against lipopolysaccharides, lipid A and proteins from Enterobacteriaceae in patients with chronic inflammatory liver diseases
4. Increased serum IgM class anti-lipid A antibody and therapeutic effect of ursodeoxycholic acid in primary biliary cirrhosis
5. A study of endotoxaemia in patients with primary biliary cirrhosis
6. Biliary secretion of endotoxin and pathogenesis of primary biliary cirrhosis
7. An experimental animal model of primary biliary cirrhosis induced by lipopolysaccharide and pyruvate dehydrogenase
8. Fas ligand expressing mononuclear cells around intrahepatic bile ducts co-express CD68 in primary biliary cirrhosis